Patient Experience Solutions

The Patient Experience Initiative developed tools to provide more effective ways to engage with patients in the design and execution of clinical studies. These tools aim to improve engagement and partnership between biopharmaceutical companies and patients to create better experiences for clinical study participants.

SURVEY LIVE – Nov 1, 2021 – Jan 31, 2022
Help TransCelerate understand your experience implementing solutions & tools aimed to improve the patient experience in clinical research. Do you work for an organization that plays a role in the design and execution of Clinical Trials such as Clinical Research Organizations, Biopharmaceutical Companies (that are not members of TransCelerate), Clinical Research Sites, Clinical Research Technology Providers, and Research Institutions (Academia)? If so, TransCelerate wants to hear from you by taking this survey! Click here to view survey details including solutions asked about in survey.

Find out more below:


Navigate to the Two Patient Experience Toolkits

Click below on the toolkit you would like to know more about.

Design clinical studies with patient inputs
Patient Protocol Engagement Toolkit
(P-PET)

A clinical study engagement toolkit composed of:

  • Sponsor-facing operational user guide*
  • Resource guide* with question bank
  • Templates to enable study sponsors to engage with patients during clinical study design

*These solutions were updated in 2021 due to the shifting environment posed by COVID-19. New considerations for caregivers and best practices for engaging patients in a virtual environment have been added. 

Gather patient feedback during clinical studies
Study Participant Feedback Questionnaire Toolkit
(SPFQ)

A clinical study participant feedback toolkit composed of:

  • Background information for initial Sponsor discussions
  • Implementation user guide
  • Set of 3 Study Participant Feedback Questionnaires (beginning, during, and end of study)

The Clinical Study

See where P-PET and SPFQ should be used during a clinical study.